The Frontal Fibrosing Alopecia Treatment Dilemma
- PMID: 38610902
- PMCID: PMC11012663
- DOI: 10.3390/jcm13072137
The Frontal Fibrosing Alopecia Treatment Dilemma
Abstract
Frontal fibrosing alopecia (FFA) is a type of cicatricial alopecia predominantly observed in postmenopausal women, with the incidence rising since its initial description in 1994. The exact etiopathogenesis of the disease has not been completely elucidated. FFA is characterized by an inflammatory process affecting the hair follicles of the fronto-temporal hairline, leading to its gradual recession. Eyebrows, particularly the lateral parts, may also be affected. Early diagnosis and an implementation of effective therapy to limit the inflammatory process are crucial in halting disease progression. Various treatment possibilities have been reported, including anti-inflammatory and immunosuppressive agents, as well as 5-alpha-reductase inhibitors, retinoids, and antimalarial agents. The use of phototherapy and surgical procedures has also been described. However, most available data have been obtained retrospectively, frequently consisting of descriptions of case reports or small case series, and not from randomized controlled trials. In addition, the etiopathogenesis of FFA remains unclear and its course unpredictable, occasionally being linked with spontaneous stabilization. Hence, no precise guidelines exist regarding treatment modalities. Therefore, the aims of this study were to provide a comprehensive review of the efficacy of existing therapeutic modalities for FFA and to highlight novel therapeutic options.
Keywords: FFA; FFA management; FFA treatment; cicatricial alopecia; frontal fibrosing alopecia; frontal hairline recession; inflammatory scalp disease.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Frontal fibrosing alopecia: efficacy of treatment modalities.Int J Womens Health. 2019 Apr 29;11:273-285. doi: 10.2147/IJWH.S177308. eCollection 2019. Int J Womens Health. 2019. PMID: 31118828 Free PMC article.
-
Frontal Fibrosing Alopecia: Successfully Treated with Methotrexate or Just the Natural Disease Progression?Acta Dermatovenerol Croat. 2020 Dec;28(3):188-189. Acta Dermatovenerol Croat. 2020. PMID: 33422174
-
Frontal Fibrosing Alopecia: Update and Review of Challenges and Successes.J Cutan Med Surg. 2018 Mar/Apr;22(2):182-189. doi: 10.1177/1203475417736279. Epub 2017 Oct 23. J Cutan Med Surg. 2018. PMID: 29056083 Review.
-
Frontal Fibrosing Alopecia in Men: A Review of the Literature.J Clin Med. 2025 Mar 12;14(6):1914. doi: 10.3390/jcm14061914. J Clin Med. 2025. PMID: 40142720 Free PMC article. Review.
-
Medical therapy for frontal fibrosing alopecia: A review and clinical approach.J Am Acad Dermatol. 2019 Aug;81(2):568-580. doi: 10.1016/j.jaad.2019.03.079. Epub 2019 Apr 3. J Am Acad Dermatol. 2019. PMID: 30953702 Review.
Cited by
-
Frontal Fibrosing Alopecia: A Comprehensive Guide for Cosmetic Dermatologists.Dermatol Ther (Heidelb). 2025 Jan;15(1):15-29. doi: 10.1007/s13555-024-01311-z. Epub 2024 Nov 28. Dermatol Ther (Heidelb). 2025. PMID: 39607666 Free PMC article. Review.
-
FFA Patient Profile Analysis Based on the Authors' Observations and a Review of the Literature-An Original Survey.J Clin Med. 2025 Jun 18;14(12):4346. doi: 10.3390/jcm14124346. J Clin Med. 2025. PMID: 40566090 Free PMC article.
References
-
- Vañó-Galván S., Molina-Ruiz A.M., Serrano-Falcón C., Arias-Santiago S., Rodrigues-Barata A.R., Garnacho-Saucedo G., Martorell-Calatayud A., Fernández-Crehuet P., Grimalt R., Aranegui B., et al. Frontal fibrosing alopecia: A multicenter review of 355 patients. J. Am. Acad. Dermatol. 2014;70:670–678. doi: 10.1016/j.jaad.2013.12.003. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources